ANTICORPOS HUMANIZADOS DIRECCIONADOS CONTRA O ANTIGENIO DE A33
A33 antigen binding proteins are described for use in the diagnosis or treatment of colorectal tumours and metastases arising therefore. The binding protein may be a humanised A33 antibody, including complete antibody molecules, fragments thereof, and, especially, multivalent monospecific proteins c...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | por |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | JOHN ROBERT ADAIR RAYMOND JOHN OWENS DAVID JOHN KING |
description | A33 antigen binding proteins are described for use in the diagnosis or treatment of colorectal tumours and metastases arising therefore. The binding protein may be a humanised A33 antibody, including complete antibody molecules, fragments thereof, and, especially, multivalent monospecific proteins comprising two, three, four or more antibodies or fragments thereof bound to each other by a cross-linking agent. For diagnosis or therapy the humanised A33 antibody may be linked to a reporter or effector molecule. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT628077EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT628077EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT628077EE3</originalsourceid><addsrcrecordid>eNrjZLBz9AvxdPYPCvAPVvAI9XX084xydAGyXTyDXJ2dPf39wDxnf7-QIEcFfwWQandXP09_BRdXBUdjYx4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEh8QYmZkYWBu7upqTFgFALrqKXU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTICORPOS HUMANIZADOS DIRECCIONADOS CONTRA O ANTIGENIO DE A33</title><source>esp@cenet</source><creator>JOHN ROBERT ADAIR ; RAYMOND JOHN OWENS ; DAVID JOHN KING</creator><creatorcontrib>JOHN ROBERT ADAIR ; RAYMOND JOHN OWENS ; DAVID JOHN KING</creatorcontrib><description>A33 antigen binding proteins are described for use in the diagnosis or treatment of colorectal tumours and metastases arising therefore. The binding protein may be a humanised A33 antibody, including complete antibody molecules, fragments thereof, and, especially, multivalent monospecific proteins comprising two, three, four or more antibodies or fragments thereof bound to each other by a cross-linking agent. For diagnosis or therapy the humanised A33 antibody may be linked to a reporter or effector molecule.</description><edition>6</edition><language>por</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020731&DB=EPODOC&CC=PT&NR=628077E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020731&DB=EPODOC&CC=PT&NR=628077E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOHN ROBERT ADAIR</creatorcontrib><creatorcontrib>RAYMOND JOHN OWENS</creatorcontrib><creatorcontrib>DAVID JOHN KING</creatorcontrib><title>ANTICORPOS HUMANIZADOS DIRECCIONADOS CONTRA O ANTIGENIO DE A33</title><description>A33 antigen binding proteins are described for use in the diagnosis or treatment of colorectal tumours and metastases arising therefore. The binding protein may be a humanised A33 antibody, including complete antibody molecules, fragments thereof, and, especially, multivalent monospecific proteins comprising two, three, four or more antibodies or fragments thereof bound to each other by a cross-linking agent. For diagnosis or therapy the humanised A33 antibody may be linked to a reporter or effector molecule.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBz9AvxdPYPCvAPVvAI9XX084xydAGyXTyDXJ2dPf39wDxnf7-QIEcFfwWQandXP09_BRdXBUdjYx4G1rTEnOJUXijNzSDv5hri7KGbWpAfn1pckJicmpdaEh8QYmZkYWBu7upqTFgFALrqKXU</recordid><startdate>20020731</startdate><enddate>20020731</enddate><creator>JOHN ROBERT ADAIR</creator><creator>RAYMOND JOHN OWENS</creator><creator>DAVID JOHN KING</creator><scope>EVB</scope></search><sort><creationdate>20020731</creationdate><title>ANTICORPOS HUMANIZADOS DIRECCIONADOS CONTRA O ANTIGENIO DE A33</title><author>JOHN ROBERT ADAIR ; RAYMOND JOHN OWENS ; DAVID JOHN KING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT628077EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2002</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>JOHN ROBERT ADAIR</creatorcontrib><creatorcontrib>RAYMOND JOHN OWENS</creatorcontrib><creatorcontrib>DAVID JOHN KING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOHN ROBERT ADAIR</au><au>RAYMOND JOHN OWENS</au><au>DAVID JOHN KING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTICORPOS HUMANIZADOS DIRECCIONADOS CONTRA O ANTIGENIO DE A33</title><date>2002-07-31</date><risdate>2002</risdate><abstract>A33 antigen binding proteins are described for use in the diagnosis or treatment of colorectal tumours and metastases arising therefore. The binding protein may be a humanised A33 antibody, including complete antibody molecules, fragments thereof, and, especially, multivalent monospecific proteins comprising two, three, four or more antibodies or fragments thereof bound to each other by a cross-linking agent. For diagnosis or therapy the humanised A33 antibody may be linked to a reporter or effector molecule.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | por |
recordid | cdi_epo_espacenet_PT628077EE |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE |
title | ANTICORPOS HUMANIZADOS DIRECCIONADOS CONTRA O ANTIGENIO DE A33 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T12%3A26%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOHN%20ROBERT%20ADAIR&rft.date=2002-07-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT628077EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |